Infectious Diseases News and Research

RSS

MDI to advance Detect-Ready MRSA Panel with $1.9M Series B recapitalization financing

Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.

16 Apr 2012

Scientists identify which T. gondii strains are linked with severe illness in U.S. infants

Scientists have identified which strains of the Toxoplasma gondii parasite, the cause of toxoplasmosis, are most strongly associated with premature births and severe birth defects in the United States.

16 Apr 2012

Next five years important for S. Africa to show it can effectively respond to HIV, TB

South Africa's recently released "National Strategic Plan on HIV, Sexually Transmitted Infections (STIs) and Tuberculosis (TB) 2012-2016" "marked an important milestone" in the nation's fight against infectious diseases, a Lancet editorial states.

16 Apr 2012

HPA urges routine vaccination after surge of whooping cough cases

The Health Protection Agency (HPA) said there have been 665 confirmed cases already this year, compared with 1,040 in the whole of 2011. Cases have been reported across all regions in England with some areas reporting clusters in schools, universities and healthcare settings.

15 Apr 2012

FDA urges restriction in injudicious use of antibiotics in livestock

The Food and Drug Administration (FDA) has urged drug companies Wednesday to help limit the use of antibiotics in farm animals. The researchers say that this decades-old practice has contributed to a surge in dangerous, drug-resistant bacteria.

12 Apr 2012

DNDi, AstraZeneca enter collaboration on drug-compound screening for NTDs

AstraZeneca and the Drugs for Neglected Diseases initiative (DNDi) today announce an agreement to collaborate on drug-compound screening for leishmaniasis, Chagas disease, and sleeping sickness, three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide.

12 Apr 2012

Discontinuing antibiotic used to prevent opportunistic infections among HIV patients could increase risk of malaria, diarrhea

"Abruptly discontinuing co-trimoxazole -- an antibiotic used to prevent opportunistic infections in HIV-positive people -- can lead to a higher incidence of malaria and diarrhea compared with patients who keep on taking the drug," according to a study conducted by the CDC in eastern Uganda and published by the Oxford Journal of Clinical Infectious Diseases in March, PlusNews reports.

12 Apr 2012

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Quest Diagnostics, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its Simplexa C. difficile Universal Direct Test on the 3M Integrated Cycler.

From Quest Diagnostics 12 Apr 2012

Computer modeling supports theory that many dementias spread like prion diseases

A new technique for analyzing brain images offers the possibility of using magnetic resonance imaging (MRI) to predict the rate of progression and physical path of many degenerative brain diseases, report scientists at the San Francisco VA Medical Center and the University of California, San Francisco.

11 Apr 2012

New WHO endorsed diagnostic tool for TB

Up to 30% of the world's population is infected with Tuberculosis (TB), but in many areas of the world, TB diagnosis still relies on insensitive, poorly standardized, and time-consuming methods. A new diagnostic tool, endorsed by the World Health Organization (WHO), may change that. Dr. Thomas Bodmer shows how it's done in the Journal of Visualized Experiments (JoVE).

9 Apr 2012

Innovative tool for tracking movement of infectious diseases

It may seem like a game of tag, but it's an innovative tool for teaching the fundamentals of epidemiology, the science of how infectious diseases move through a population.

7 Apr 2012

Antibiotics may have absolutely no effect within a few decades

The increased resistance of bacteria to antibiotics is a global problem. Antibiotics are increasingly less effective. Microbiologist Dr. John Hays of Erasmus MC in Rotterdam is sounding the alarm: "The problem is so dire that within a few decades antibiotics will have absolutely no effect".

6 Apr 2012

Advaxis, Karolinska Institutet enter collaboration to develop cat allergy vaccine

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has entered into a research collaboration with Professor Marianne van Hage, research group leader and Head of the Clinical Immunology and Allergy Unit and Vice Head of the Department of Medicine at Karolinska Institutet in Stockholm, Sweden.

6 Apr 2012

Fogarty receives NIH grant to help foster next generation of global health scientists

To help foster the next generation of global health scientists, Fogarty International Center and its partners at the National Institutes of Health are building a network of U.S. academic institutions to provide early-career physicians, veterinarians, dentists and scientists with a significant mentored research experience in a developing country.

5 Apr 2012

Results from Abbott’s multiple interferon-free Phase 2 HCV studies to be presented at ILC 2012

Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.

5 Apr 2012

Ventria completes VEN100 phase 2 trial on antibiotic-associated diarrhea

Ventria Bioscience has announced the successful completion of a phase 2 clinical trial of its lead therapeutic candidate, VEN100. The study was conducted by a team of investigators from the Department of Epidemiology, Division of Infectious Diseases, and Division of Geriatric Medicine at Johns Hopkins University.

5 Apr 2012

Nuvilex realizes important role for Cell-in-a-Box technology

Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions through acquisition of SG Austria assets, realizes the important role for Cell-in-a-Box technology and aims to bring to light its use in the production of therapeutic antibodies for clinically important diseases.

4 Apr 2012

Infectious Diseases News and Research

MDI to advance Detect-Ready MRSA Panel with $1.9M Series B recapitalization financing

Scientists identify which T. gondii strains are linked with severe illness in U.S. infants

Next five years important for S. Africa to show it can effectively respond to HIV, TB

HPA urges routine vaccination after surge of whooping cough cases

FDA urges restriction in injudicious use of antibiotics in livestock

DNDi, AstraZeneca enter collaboration on drug-compound screening for NTDs

Discontinuing antibiotic used to prevent opportunistic infections among HIV patients could increase risk of malaria, diarrhea

Quest Diagnostics receives FDA clearance for Simplexa C. difficile Universal Direct test

Computer modeling supports theory that many dementias spread like prion diseases

New WHO endorsed diagnostic tool for TB

Innovative tool for tracking movement of infectious diseases

Antibiotics may have absolutely no effect within a few decades

Advaxis, Karolinska Institutet enter collaboration to develop cat allergy vaccine

Fogarty receives NIH grant to help foster next generation of global health scientists

Results from Abbott’s multiple interferon-free Phase 2 HCV studies to be presented at ILC 2012

Ventria completes VEN100 phase 2 trial on antibiotic-associated diarrhea

Nuvilex realizes important role for Cell-in-a-Box technology

MedImmune's quadrivalent flu vaccine may protect children

Positive outcome from AiCuris’ Letermovir phase 2b trial on HCMV infections

Merck announces data from ZOSTAVAX Phase III study on shingles

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News